Todd Branning
Chief Executive Officer at NEUBASE THERAPEUTICS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Adam Buchen | M | 59 |
Amneal Pharma UK Holdings Ltd.
 Amneal Pharma UK Holdings Ltd. Medical DistributorsDistribution Services Part of Amneal Pharmaceuticals, Inc., Amneal Pharma UK Holdings Ltd. is a company that sells pharmaceutical products. Amneal Pharma UK Holdings Ltd. is based in Felsted, UK. Founded in 2013. | 2 years |
| Dov Goldstein | M | 56 | 5 years | |
| Eric Richman | M | 63 | 5 years | |
| Paul Meister | M | 71 |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | 5 years |
| Shlomo Yanai | M | 71 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | 5 years |
| Gerald McDougall | M | 57 | 3 years | |
| Jeffrey George | M | 51 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | 5 years |
| John Kiely | M | 66 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | 5 years |
| Philip Broomhead | M | 62 |
Amneal UK Holding Co. Ltd.
 Amneal UK Holding Co. Ltd. Financial ConglomeratesFinance Part of Amneal Pharmaceuticals, Inc., Amneal UK Holding Co. Ltd. is a company that functions as an investment holding company. Amneal UK Holding Co. Ltd. is based in London, UK. Founded in 2017.
Amneal Pharma UK Holdings Ltd.
Amneal Pharma UK Holdings Ltd. Medical DistributorsDistribution Services Part of Amneal Pharmaceuticals, Inc., Amneal Pharma UK Holdings Ltd. is a company that sells pharmaceutical products. Amneal Pharma UK Holdings Ltd. is based in Felsted, UK. Founded in 2013. | - |
| Shannon McCarthy | F | - | - | |
| Alan Scrivner | M | - | 3 years | |
| Ron Sarkar | M | - | 3 years | |
| Dani Stoltzfus | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dietrich Stephan | M | 54 | 15 years | |
| Paul Bisaro | M | 63 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | 6 years |
| Scott Giacobello | M | 54 | 7 years | |
| Brenton Saunders | M | 56 | 6 years | |
| Robert Stewart | M | 56 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | 1 years |
| Andrew L. Turner | M | 77 | 2 years | |
| John Kelly | M | 57 | 6 years | |
| Jean Selden Greene | F | 51 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | - |
| Nesli Basgoz | M | 66 | 6 years | |
| C. Nicholson | M | 69 | 6 years | |
| William Mann | M | 63 | 2 years | |
| Christopher Coughlin | M | 71 | 6 years | |
| Roger Ulrich | M | - | 3 years | |
| Jirí Michal | M | 71 | 2 years | |
| Dharmendra J. Rama | M | 55 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | - |
| Peter John McDonnell | M | 66 | 5 years | |
| Stephen J. Manzano | M | 59 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | 2 years |
| Jonathon Kellerman | M | - | 6 years | |
| Sigurdur Olafsson | M | 55 | 4 years | |
| Ambrose Bailey | M | 60 | 6 years | |
| John A. King | M | 74 | 2 years | |
| George Wilkinson | M | 68 | 1 years | |
| Shankar Hariharan | M | - |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | 9 years |
| Janet Vergis | F | 59 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | 4 years |
| Robert Todd Joyce | M | 66 | 1 years | |
| James Topper | M | 62 | 3 years | |
| Michael R. Gallagher | M | 77 | 2 years | |
| Robert L. Burr | M | 73 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | - |
| James H. Bloem | M | 73 | 5 years | |
| Hafrun Fridriksdottir | M | 62 | 14 years | |
| Patrick O’Sullivan | M | 82 | 5 years | |
| Jeff Zerillo | M | 63 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | 2 years |
| Megan Schoeps | F | 40 | 2 years | |
| Sue-Jean Lin | F | 65 | 26 years | |
| David Melnick | M | 72 | - | |
| Herm Cukier | M | 57 | 5 years | |
| Yao Lee | M | 54 | 4 years | |
| Carlos Campoy | M | 60 | 2 years | |
| Nori Ebersole | F | 60 | 18 years | |
| Ian A. Critchley | M | - | 3 years | |
| Daniel Motto | M | - | 6 years | |
| Abbey Jenkins | F | - | 2 years | |
| Michael Towers | M | - | 5 years | |
| Pradeep Bhadauria | M | - |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | - |
| Sailaja Puttagunta | M | 55 | 1 years | |
| Kathleen Reape | M | 58 | 1 years | |
| Matthew Moore | M | 51 | 5 years | |
| Kathryn DiMarco | F | 57 | 5 years | |
| Howard Cyr | M | - |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | 8 years |
| Keren Haruvi | F | 44 |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | 1 years |
| Karah Parschauer | F | 46 | 11 years | |
| Patrick Spicer | M | - | - | |
| John W. LaRocca | M | 59 | 1 years | |
| Michael Rowe | M | 62 | 6 years | |
| Maria Hilado | F | 59 | 4 years | |
| Richard Spivey | M | 74 | 5 years | |
| Jack Michelson | M | 89 | 1 years | |
| James O'Brien | M | 57 | 3 years | |
| William Meury | M | 56 | 6 years | |
| James D'Arecca | M | 53 | 7 years | |
| William Kane | M | 62 | 7 years | |
| Gavin R. Corcoran | M | 61 | 4 years | |
| Eric Ende | M | 55 | 1 years | |
| Jonathan Garen | M | 58 | - | |
| Leonard Dove | M | 51 | 2 years | |
| Michael Dunne | M | 64 | 1 years | |
| Charles M. Mayr | M | 67 | 3 years | |
| Paul Navarre | M | - | - | |
| Tina Devries | M | 63 | 1 years | |
| Sandra Porcile Rojas-Caro | M | 55 | 1 years | |
| George Brady | M | - | - | |
| Karen Ling | F | 60 | 5 years | |
| Thomas Nee | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 57 | 66.28% |
| United States | 29 | 33.72% |
| United Kingdom | 2 | 2.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Todd Branning
- Personal Network
